2008
DOI: 10.1016/j.jaci.2007.12.1095
|View full text |Cite
|
Sign up to set email alerts
|

Establishment of a Model to Objectively Examine Maximal Nasal Decongestion Using a Clinically Available Antihistamine/decongestant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A response to the allergen (as evidenced by a reduction in A min and nasal volume values) was seen in all treatment groups, but there was no significant treatment effect on A min proportion or nasal volume proportion for any treatments, including fexofenadine/pseudoephedrine. On the basis of a previous allergen challenge methodology study 11 in which fexofenadine/pseudoephedrine partially attenuated allergen-induced reduction of A min and nasal volume values, the lack of statistically significant inhibition was not expected. Indeed, the same general methodology was used in both studies.…”
Section: Discussionmentioning
confidence: 90%
“…A response to the allergen (as evidenced by a reduction in A min and nasal volume values) was seen in all treatment groups, but there was no significant treatment effect on A min proportion or nasal volume proportion for any treatments, including fexofenadine/pseudoephedrine. On the basis of a previous allergen challenge methodology study 11 in which fexofenadine/pseudoephedrine partially attenuated allergen-induced reduction of A min and nasal volume values, the lack of statistically significant inhibition was not expected. Indeed, the same general methodology was used in both studies.…”
Section: Discussionmentioning
confidence: 90%